Literature DB >> 32691724

Restless legs syndrome associated with use of stevia nonnutritive sweetener.

Umesh Goswami1, Snigdha Pusalavidyasagar1.   

Abstract

None: Restless legs syndrome is a common sensorimotor movement disorder affecting an estimated 15-20% of the general adult population in the United Sates. Several drugs and drug classes have been shown to either cause and/or exacerbate symptoms of restless legs syndrome. With the epidemic of obesity and the heightened awareness of the harmful effects of added sugars, the consumption of low and no-calorie sweeteners has substantially increased. We report a case where the patient developed restless legs syndrome symptoms with the use of a stevia extract-based no calorie sweetener. To our knowledge, this is the first case report of restless legs syndrome possibly associated with low or no-calorie sweetener use.
© 2020 American Academy of Sleep Medicine.

Entities:  

Keywords:  RLS; dopamine; obesity; restless legs syndrome; stevia

Mesh:

Substances:

Year:  2020        PMID: 32691724      PMCID: PMC7953997          DOI: 10.5664/jcsm.8702

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  9 in total

1.  Consumption of Low-Calorie Sweeteners among Children and Adults in the United States.

Authors:  Allison C Sylvetsky; Yichen Jin; Elena J Clark; Jean A Welsh; Kristina I Rother; Sameera A Talegawkar
Journal:  J Acad Nutr Diet       Date:  2017-01-10       Impact factor: 4.910

Review 2.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

3.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

4.  Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana.

Authors:  Naveen Shivanna; Mahadev Naika; Farhath Khanum; Vijay K Kaul
Journal:  J Diabetes Complications       Date:  2012-11-07       Impact factor: 2.852

5.  Biochemical and histological changes produced by sweeteners and cytarabine in the brain of young rats.

Authors:  Ernestina Hernández García; Norma Osnaya Brizuela; Armando Valenzuela Peraza; David Calderón Guzmán; Maribel Ortiz Herrera; Hugo Juárez Olguín; Gerardo Barragán Mejía; Daniel Santamaría Del Ángel; Alberto Rojas Ochoa
Journal:  Nutr Hosp       Date:  2018-02-13       Impact factor: 1.057

Review 6.  Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies.

Authors:  Lisa Te Morenga; Simonette Mallard; Jim Mann
Journal:  BMJ       Date:  2012-01-15

7.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.

Authors:  W Timothy Garvey; Jeffrey I Mechanick; Elise M Brett; Alan J Garber; Daniel L Hurley; Ania M Jastreboff; Karl Nadolsky; Rachel Pessah-Pollack; Raymond Plodkowski
Journal:  Endocr Pract       Date:  2016-05-24       Impact factor: 3.443

Review 8.  Stevioside and related compounds: therapeutic benefits beyond sweetness.

Authors:  Varanuj Chatsudthipong; Chatchai Muanprasat
Journal:  Pharmacol Ther       Date:  2008-10-27       Impact factor: 12.310

9.  Low-calorie sweeteners and body weight and composition: a meta-analysis of randomized controlled trials and prospective cohort studies.

Authors:  Paige E Miller; Vanessa Perez
Journal:  Am J Clin Nutr       Date:  2014-06-18       Impact factor: 7.045

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.